A World Health Organization (WHO) expert panel countered concerns over the efficacy of the AstraZeneca COVID vaccine on Wednesday, insisting that “it’s
The top infectious disease expert in the U.S. warned Monday of a “surge upon a surge” of coronavirus cases as Americans travel for holidays.
More
Countries fighting the coronavirus should not impose nationwide or large-scale school closures, which is the wrong response and compounds the societal cost of the disease, with 320 million children locked out of school at the start of December, the UN children’s agency UNICEF said on Tuesday.
More
In the United States, there is not yet an authorized or approved vaccine to prevent coronavirus disease 2019 (COVID-19). With the possibility of a limited supply of one or more COVID-19 vaccines becoming available before the end of 2020, accurate vaccine information is critical.
More
We understand that some people may be concerned about getting vaccinated once a COVID-19 vaccine is available in the United States. While these vaccines are being developed as quickly as possible, routine processes and procedures remain in place to ensure the safety of any vaccine that is authorized or approved for use. Safety is a
More
Scientists developing COVID-19 vaccines are optimistic that by the end of next year, all people everywhere will have access to safe and effective treatments against a disease which has disrupted the entire planet.
More
As world leaders gather virtually at the Special Session of the General Assembly in response to the COVID-19 pandemic, new data published today finds that leaving low- and lower-middle-income countries (LLMICs) without access to vaccines amid the COVID-19 pandemic will cause significant economic damage that puts decades of economic progress at risk – for both
More
U.S. President-elect Joe Biden met virtually Wednesday with American small-business owners and workers who have been impacted by the economic slowdown caused by the coronavirus pandemic.
More
The Asian Development Bank (ADB) today approved a $100 million grant to help the Government of Afghanistan respond to the coronavirus disease (COVID-19) pandemic.
More
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe
More